Translational Neuroscience

Top Research Topics at Translational Neuroscience?

The journal tackles a plethora of topics, such as Neuroscience, Neurology, Internal medicine, Pharmacology and Cognition. The Neuroscience works featured in the journal incorporate elements from Schizophrenia and Neurodegeneration. The journal holds forums on Neurology that merges themes from other disciplines such as Neurosurgery and Disease, Pathology.

The Disease research dealing mostly with Dementia is the focus of the journal. While work presented in Translational Neuroscience provided substantial information on Internal medicine, it also covered topics in Gastroenterology, Endocrinology and Cardiology. While Pharmacology is the focus of Translational Neuroscience, it also provided insights into the studies of Oxidative stress and Ischemia.

The studies on Cognition discussed can also contribute to research in the domains of Developmental psychology and Cognitive psychology.

• Neuroscience (25.92%)
• Neurology (14.47%)
• Internal medicine (14.25%)

What are the most cited papers published in the journal?

• Soluble forms of tau are toxic in Alzheimer’s disease (132 citations)
• ISS-N1 makes the First FDA-approved Drug for Spinal Muscular Atrophy. (97 citations)
• Homeostatic function of astrocytes: Ca(2+) and Na(+) signalling (86 citations)

Research areas of the most cited articles at Translational Neuroscience:

The published papers mostly deal with topics like Neuroscience, Cognition, Neurology, Autism and Disease. The most cited publications dive deep in exploring the relationship between the study of Neuroscience and Intracellular. The most cited publications explore topics in Cognition which can be helpful for research in disciplines like Dementia and Neuroimaging.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Neuroscience

The previous edition focused in particular on these issues:

The scientific interests tackled in the journal are Cancer research, Neuroprotection, Pharmacology, Neuroscience and Glioma. It focuses on Cancer research but the discussions also offer insight into other areas such as Carcinogenesis, Transfection, KEGG, microRNA and Western blot. Oxidative stress, Endocrinology and Gap junction are some topics wherein Neuroprotection research discussed in the journal have an impact.

The research on Pharmacology tackled can also make contributions to studies in the areas of Reperfusion injury, Ischemia and Magnetic resonance imaging. The journal explores Neuroscience concepts, specifically Seizure activity but expands to research in Mechanism (biology). Glioma research featured in it incorporates concerns from various other topics such as Epithelial–mesenchymal transition, Protein kinase B, Gene knockdown and Survivin.

The most cited articles from the last journal are:

• Pelargonidin ameliorates MCAO-induced cerebral ischemia/reperfusion injury in rats by the action on the Nrf2/HO-1 pathway. (2 citations)
• Lepidium sativum as candidate against excitotoxicity in retinal ganglion cells. (1 citations)
• Naringin attenuates cerebral ischemia-reperfusion injury in rats by inhibiting endoplasmic reticulum stress. (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Translational Neuroscience (based on the number of publications) are:

• Patrick R. Hof (16 papers) absent at the last edition,
• Goran Šimić (15 papers) absent at the last edition,
• Manuel F. Casanova (11 papers) absent at the last edition,
• Miloš Judaš (8 papers) absent at the last edition,
• Min Cheol Chang (8 papers) published 1 paper at the last edition, 6 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Translational Neuroscience (based on the number of publications) are:

• University of Zagreb (42 papers) absent at the last edition,
• Icahn School of Medicine at Mount Sinai (26 papers) absent at the last edition,
• Yeungnam University (14 papers) published 1 paper at the last edition, 7 less than at the previous edition,
• Jilin University (12 papers) published 1 paper at the last edition,
• University of Louisville (11 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.56% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.71% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.76% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.71% of all publications and 58.82% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Paths in Neuroscience

Embracing a career in neuroscience research can lead to numerous paths. Apart from publishing research papers and contributing to the knowledge pool on cognition, neurology, and medicine, various career paths can include taking on roles as neurologists, psychiatrists, psychologists, neurosurgeons, and speech therapists. Transitioning to these roles require various forms of qualifications, training, and certification.

For example, if you aspire to become a speech therapist in Colorado, you will need to earn a master's degree in Speech-Language Pathology, complete a Clinical Fellowship, and pass a national examination. Specific guidelines can be found on how to fulfill these requirements. For your benefit, we have prepared an elaborate guide on how to become a speech therapist in Colorado.

In conclusion, the field of neuroscience offers a wide range of interesting and impactful careers, providing numerous opportunities for researchers to make significant contributions to our understanding of the human brain, cognition, neurologic disorders, and potential treatments.